Testing effectiveness (Phase 2)Study completedNCT03685448
What this trial is testing
ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)
Who this might be right for
Renal Cell CarcinomaPapillary Renal Cell Carcinoma Type 1Papillary Renal Cell Carcinoma Type 2+3 more
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 35